Literature DB >> 23614616

MicroRNAs as new diagnostic and prognostic biomarkers in urological tumors.

Annika Fendler1, Klaus Jung.   

Abstract

MicroRNAs are single-stranded regulatory molecules that play an important role during carcinogenesis. Since microRNA expressions are deregulated in cancer and they have proven to be very stable in clinical specimens, they have become attractive molecules as markers for the diagnosis and prognosis, as well as for prediction of therapy response and surveillance, of cancer. In this review, we summarize the latest findings on microRNAs in tissue and body fluids of patients suffering from urological tumors and their utilization as noninvasive or tissue markers for detection and stratification of these tumors.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23614616     DOI： 10.1615/critrevoncog.2013007176

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN： 0893-9675


  12 in total

Review 1.  MicroRNA in chronic rhinosinusitis and allergic rhinitis.

Authors:  Xin-Hao Zhang; Ya-Na Zhang; Zheng Liu
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

2.  [Epigenetics in urothelial cancer: Pathogenesis, improving diagnostics and developing novel treatment options].

Authors:  G Niegisch; M J Hoffmann; E A Koutsogiannouli; W A Schulz
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

3.  MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.

Authors:  Naibijiang Maolakuerban; Baihetiya Azhati; Hamulati Tusong; Asimujiang Abula; Anniwaer Yasheng; Ayiding Xireyazidan
Journal:  Cancer Biol Ther       Date:  2018-02-02       Impact factor: 4.742

4.  Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression.

Authors:  Priyanka Kulkarni; Pritha Dasgupta; Nadeem S Bhat; Varahram Shahryari; Marisa Shiina; Yutaka Hashimoto; Shahana Majid; Guoren Deng; Sharanjot Saini; Z Laura Tabatabai; Soichiro Yamamura; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Mol Cancer Res       Date:  2018-07-23       Impact factor: 5.852

5.  MicroRNA-17 family as novel biomarkers for cancer diagnosis: a meta-analysis based on 19 articles.

Authors:  Ronghe Gu; Shiqing Huang; Weiguo Huang; Yuming Li; Huijiang Liu; Lijing Yang; Zhonggui Huang
Journal:  Tumour Biol       Date:  2015-12-02

6.  Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.

Authors:  Lin Lei; Yaping Huang; Wenrong Gong
Journal:  Mol Cell Biochem       Date:  2013-10-27       Impact factor: 3.396

7.  MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.

Authors:  Savita Singh; Girish C Shukla; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

8.  Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

Authors:  W Li; M Liu; Y Feng; Y-F Xu; Y-F Huang; J-P Che; G-C Wang; X-D Yao; J-H Zheng
Journal:  Br J Cancer       Date:  2014-07-10       Impact factor: 7.640

9.  Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.

Authors:  Julia Liep; Ergin Kilic; Hellmuth A Meyer; Jonas Busch; Klaus Jung; Anja Rabien
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  Nucleotide specificity of the human terminal nucleotidyltransferase Gld2 (TUT2).

Authors:  Christina Z Chung; David Hyung Suk Jo; Ilka U Heinemann
Journal:  RNA       Date:  2016-06-09       Impact factor: 4.942
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.